DaVita Inc. (0I7E.L)
USD 140.53
(-0.62%)
USD 140.53
(-0.62%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.6 Billion USD | 19.56% |
| 2022 | 1.33 Billion USD | -25.5% |
| 2021 | 1.79 Billion USD | 6.06% |
| 2020 | 1.69 Billion USD | 3.12% |
| 2019 | 1.64 Billion USD | 7.7% |
| 2018 | 1.52 Billion USD | -15.83% |
| 2017 | 1.81 Billion USD | -4.32% |
| 2016 | 1.89 Billion USD | 61.83% |
| 2015 | 1.17 Billion USD | -35.5% |
| 2014 | 1.81 Billion USD | 17.1% |
| 2013 | 1.55 Billion USD | 19.51% |
| 2012 | 1.29 Billion USD | 14.71% |
| 2011 | 1.13 Billion USD | 13.42% |
| 2010 | 997.02 Million USD | 6.04% |
| 2009 | 940.27 Million USD | 14.42% |
| 2008 | 821.76 Million USD | -4.69% |
| 2007 | 862.2 Million USD | 16.6% |
| 2006 | 739.43 Million USD | 58.89% |
| 2005 | 465.37 Million USD | 13.47% |
| 2004 | 410.12 Million USD | 8.34% |
| 2003 | 378.53 Million USD | -3.27% |
| 2002 | 391.33 Million USD | 23.06% |
| 2001 | 317.99 Million USD | 77.38% |
| 2000 | 179.27 Million USD | 136.43% |
| 1999 | 75.82 Million USD | -65.54% |
| 1998 | 220 Million USD | 175.34% |
| 1997 | 79.9 Million USD | 64.07% |
| 1996 | 48.7 Million USD | 163.24% |
| 1995 | 18.5 Million USD | 7.56% |
| 1994 | 17.2 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 483.84 Million USD | 17.83% |
| 2024 Q3 | 534.87 Million USD | 6.78% |
| 2024 Q2 | 500.91 Million USD | 3.53% |
| 2023 Q1 | 311.64 Million USD | 21.62% |
| 2023 Q3 | 495.93 Million USD | 22.37% |
| 2023 Q4 | 410.63 Million USD | -17.2% |
| 2023 FY | 1.6 Billion USD | 19.56% |
| 2023 Q2 | 405.29 Million USD | 30.05% |
| 2022 Q2 | 432.71 Million USD | 27.91% |
| 2022 Q1 | 338.3 Million USD | -13.12% |
| 2022 FY | 1.33 Billion USD | -25.5% |
| 2022 Q3 | 311.78 Million USD | -27.95% |
| 2022 Q4 | 256.25 Million USD | -17.81% |
| 2021 Q2 | 490.47 Million USD | 10.82% |
| 2021 Q1 | 442.6 Million USD | 15.96% |
| 2021 Q3 | 474.87 Million USD | -3.18% |
| 2021 Q4 | 389.41 Million USD | -18.0% |
| 2021 FY | 1.79 Billion USD | 6.06% |
| 2020 Q3 | 437.66 Million USD | 6.77% |
| 2020 FY | 1.69 Billion USD | 3.12% |
| 2020 Q2 | 409.92 Million USD | -11.92% |
| 2020 Q1 | 465.37 Million USD | 0.6% |
| 2020 Q4 | 381.67 Million USD | -12.79% |
| 2019 FY | 1.64 Billion USD | 7.7% |
| 2019 Q2 | 461.88 Million USD | 35.65% |
| 2019 Q4 | 462.58 Million USD | 22.27% |
| 2019 Q1 | 340.5 Million USD | -12.22% |
| 2019 Q3 | 378.33 Million USD | -18.09% |
| 2018 Q1 | 410.68 Million USD | 173.18% |
| 2018 Q4 | 387.9 Million USD | 34.21% |
| 2018 Q2 | 438.19 Million USD | 6.7% |
| 2018 Q3 | 289.03 Million USD | -34.04% |
| 2018 FY | 1.52 Billion USD | -15.83% |
| 2017 Q4 | 150.33 Million USD | 178.09% |
| 2017 Q3 | -192.52 Million USD | -150.89% |
| 2017 FY | 1.81 Billion USD | -4.32% |
| 2017 Q1 | 888.23 Million USD | 132.87% |
| 2017 Q2 | 378.31 Million USD | -57.41% |
| 2016 Q1 | 364.88 Million USD | 48.97% |
| 2016 Q4 | 381.42 Million USD | -53.44% |
| 2016 Q3 | 819.15 Million USD | 148.93% |
| 2016 FY | 1.89 Billion USD | 61.83% |
| 2016 Q2 | 329.07 Million USD | -9.82% |
| 2015 Q3 | 509.36 Million USD | 6.0% |
| 2015 Q2 | 480.54 Million USD | 849.03% |
| 2015 Q1 | -64.15 Million USD | -114.19% |
| 2015 FY | 1.17 Billion USD | -35.5% |
| 2015 Q4 | 244.93 Million USD | -51.91% |
| 2014 Q3 | 437.53 Million USD | -9.66% |
| 2014 Q1 | 441.22 Million USD | -8.87% |
| 2014 Q4 | 452.08 Million USD | 3.33% |
| 2014 FY | 1.81 Billion USD | 17.1% |
| 2014 Q2 | 484.29 Million USD | 9.76% |
| 2013 FY | 1.55 Billion USD | 19.51% |
| 2013 Q4 | 484.17 Million USD | 28.4% |
| 2013 Q3 | 377.07 Million USD | -27.77% |
| 2013 Q2 | 522.02 Million USD | 212.85% |
| 2013 Q1 | 166.86 Million USD | -57.0% |
| 2012 Q3 | 340.85 Million USD | 37.51% |
| 2012 Q1 | 320.72 Million USD | -2.85% |
| 2012 Q2 | 247.88 Million USD | -22.71% |
| 2012 Q4 | 388.05 Million USD | 13.85% |
| 2012 FY | 1.29 Billion USD | 14.71% |
| 2011 Q2 | 247.04 Million USD | 4.88% |
| 2011 Q4 | 330.11 Million USD | 3.58% |
| 2011 FY | 1.13 Billion USD | 13.42% |
| 2011 Q1 | 235.55 Million USD | -7.77% |
| 2011 Q3 | 318.71 Million USD | 29.01% |
| 2010 FY | 997.02 Million USD | 6.04% |
| 2010 Q4 | 255.4 Million USD | -0.46% |
| 2010 Q3 | 256.59 Million USD | 5.87% |
| 2010 Q2 | 242.36 Million USD | -0.12% |
| 2010 Q1 | 242.66 Million USD | 1.66% |
| 2009 FY | 940.27 Million USD | 14.42% |
| 2009 Q4 | 238.71 Million USD | -2.57% |
| 2009 Q3 | 245 Million USD | 3.83% |
| 2009 Q2 | 235.95 Million USD | 6.96% |
| 2009 Q1 | 220.6 Million USD | 4.26% |
| 2008 Q2 | 205.55 Million USD | 4.49% |
| 2008 Q1 | 196.72 Million USD | 0.75% |
| 2008 FY | 821.76 Million USD | -4.69% |
| 2008 Q4 | 211.6 Million USD | 1.79% |
| 2008 Q3 | 207.88 Million USD | 1.13% |
| 2007 Q1 | 193.31 Million USD | 2.55% |
| 2007 Q4 | 195.26 Million USD | -8.07% |
| 2007 Q3 | 212.41 Million USD | -18.68% |
| 2007 Q2 | 261.21 Million USD | 35.12% |
| 2007 FY | 862.2 Million USD | 16.6% |
| 2006 FY | 739.43 Million USD | 58.89% |
| 2006 Q4 | 188.51 Million USD | -13.17% |
| 2006 Q3 | 217.09 Million USD | 26.4% |
| 2006 Q2 | 171.75 Million USD | 5.97% |
| 2006 Q1 | 162.07 Million USD | 18.54% |
| 2005 Q2 | 110.31 Million USD | 4.07% |
| 2005 FY | 465.37 Million USD | 13.47% |
| 2005 Q4 | 136.72 Million USD | 21.71% |
| 2005 Q3 | 112.33 Million USD | 1.83% |
| 2005 Q1 | 105.99 Million USD | 0.78% |
| 2004 FY | 410.12 Million USD | 8.34% |
| 2004 Q4 | 105.17 Million USD | -5.8% |
| 2004 Q3 | 111.65 Million USD | 15.74% |
| 2004 Q2 | 96.46 Million USD | -0.38% |
| 2004 Q1 | 96.83 Million USD | -20.1% |
| 2003 Q3 | 95.21 Million USD | 14.99% |
| 2003 Q2 | 82.8 Million USD | 4.37% |
| 2003 FY | 378.53 Million USD | -3.27% |
| 2003 Q1 | 79.33 Million USD | -33.99% |
| 2003 Q4 | 121.19 Million USD | 27.29% |
| 2002 Q2 | 80.91 Million USD | -89.75% |
| 2002 Q1 | 789.18 Million USD | 949.09% |
| 2002 Q3 | 111.32 Million USD | 37.59% |
| 2002 FY | 391.33 Million USD | 23.06% |
| 2002 Q4 | 120.17 Million USD | 7.95% |
| 2001 Q3 | 96.86 Million USD | 37.53% |
| 2001 FY | 317.99 Million USD | 77.38% |
| 2001 Q1 | 75.46 Million USD | 45.71% |
| 2001 Q4 | 75.22 Million USD | -22.34% |
| 2001 Q2 | 70.43 Million USD | -6.67% |
| 2000 Q4 | 51.79 Million USD | 3.78% |
| 2000 Q1 | 40.31 Million USD | 240.59% |
| 2000 Q3 | 49.9 Million USD | 33.95% |
| 2000 FY | 179.27 Million USD | 136.43% |
| 2000 Q2 | 37.25 Million USD | -7.59% |
| 1999 Q2 | 10.9 Million USD | -84.41% |
| 1999 FY | 75.82 Million USD | -65.54% |
| 1999 Q1 | 69.9 Million USD | 73.02% |
| 1999 Q4 | -28.67 Million USD | -178.14% |
| 1999 Q3 | 36.7 Million USD | 236.7% |
| 1998 Q1 | 50.7 Million USD | 110.37% |
| 1998 FY | 220 Million USD | 175.34% |
| 1998 Q4 | 40.4 Million USD | -41.53% |
| 1998 Q3 | 69.1 Million USD | 15.75% |
| 1998 Q2 | 59.7 Million USD | 17.75% |
| 1997 FY | 79.9 Million USD | 64.07% |
| 1997 Q3 | 21.1 Million USD | 12.83% |
| 1997 Q2 | 18.7 Million USD | 17.61% |
| 1997 Q1 | 15.9 Million USD | 10.42% |
| 1997 Q4 | 24.1 Million USD | 14.22% |
| 1996 Q1 | 9.5 Million USD | 14.46% |
| 1996 Q2 | 11.6 Million USD | 22.11% |
| 1996 Q3 | 13.1 Million USD | 12.93% |
| 1996 Q4 | 14.4 Million USD | 9.92% |
| 1996 FY | 48.7 Million USD | 163.24% |
| 1995 Q4 | 8.3 Million USD | 10.67% |
| 1995 Q3 | 7.5 Million USD | 113.16% |
| 1995 FY | 18.5 Million USD | 7.56% |
| 1995 Q2 | -57 Million USD | -329.84% |
| 1995 Q1 | 24.8 Million USD | 0.4% |
| 1994 Q4 | 24.7 Million USD | 0.0% |
| 1994 FY | 17.2 Million USD | 0.0% |
| 1994 Q3 | 24.7 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Phreesia, Inc. | -131.77 Million USD | 1316.322% |
| Accuray Incorporated | 504 Thousand USD | -317912.698% |
| Align Technology, Inc. | 643.33 Million USD | -149.136% |
| Elevance Health Inc. | 133.96 Billion USD | 98.804% |
| AxoGen, Inc. | -21.46 Million USD | 7568.009% |
| Boston Scientific Corporation | 2.34 Billion USD | 31.593% |
| CVS Health Corporation | 13.74 Billion USD | 88.337% |
| Cardinal Health, Inc. | 1.24 Billion USD | -28.945% |
| Centene Corporation | 2.93 Billion USD | 45.297% |
| HCA Healthcare, Inc. | 9.62 Billion USD | 83.351% |
| Hologic, Inc. | 970.2 Million USD | -65.201% |
| Humana Inc. | 4.01 Billion USD | 60.06% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | -46.089% |
| Laboratory Corporation of America Holdings | 725.6 Million USD | -120.891% |
| Masimo Corporation | 136.5 Million USD | -1074.201% |
| McKesson Corporation | 3.9 Billion USD | 58.998% |
| Patterson Companies, Inc. | 252.92 Million USD | -533.702% |
| Quest Diagnostics Incorporated | 1.26 Billion USD | -27.003% |
| ResMed Inc. | 1.31 Billion USD | -21.433% |
| Henry Schein, Inc. | 615 Million USD | -160.615% |
| Teladoc Health, Inc. | -248.55 Million USD | 744.846% |
| Universal Health Services, Inc. | 1.17 Billion USD | -36.363% |
| Veeva Systems Inc. | 429.33 Million USD | -273.319% |
| Baxter International Inc. | 390 Million USD | -310.97% |
| Becton, Dickinson and Company | 2.11 Billion USD | 24.075% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | 9.283% |
| Danaher Corporation | 5.38 Billion USD | 70.214% |
| Stryker Corporation | 3.88 Billion USD | 58.776% |
| Medtronic plc | 5.14 Billion USD | 68.842% |